518 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Not yet recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
3 Not yet recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
4 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
5 Recruiting Phase 1 and 2 Study of MEDI4736 in Combination With Olaparib or Cediranib for Advanced Solid Tumors and Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Solid Tumors
Interventions: Drug: Olaparib;   Drug: Cediranib;   Drug: MEDI4736
6 Recruiting Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: veliparib;   Drug: carboplatin;   Drug: paclitaxel
7 Recruiting Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst
Condition: Ovarian Cyst
Intervention: Other: Hormonal analysis, pelvic US
8 Not yet recruiting Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours
Condition: Ovarian Cancer,
Intervention: Drug: AZD 1775
9 Not yet recruiting TIL Therapy for Metastatic Ovarian Cancer
Condition: Metastatic Ovarian Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: TIL infusion;   Drug: Interleukin-2
10 Recruiting Venous Thromboembolic Complications in Ovarian Cancer
Conditions: Venous Thromboembolism;   Ovarian Neoplasms;   Ovarian Cancer;   Deep Vein Thrombosis;   Lung Embolism
Intervention:
11 Not yet recruiting Study of Safety & Biological Activity of IP GEN-1 With Neoadjuvant Chemo in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Intervention: Biological: GEN-1
12 Not yet recruiting DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Intervention:
13 Recruiting Platine, Avastin and OLAparib in 1st Line
Condition: Ovarian Cancer
Interventions: Drug: Olaparib;   Drug: Placebo
14 Recruiting Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI
Conditions: In Vitro Fertilization;   Polycystic Ovary Syndrome
Interventions: Drug: Long-acting Triptorelin;   Drug: Short-acting Triptorelin
15 Recruiting Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Condition: Epithelial Ovarian Cancer
Intervention: Device: Mirena® intra-uterine device (IUD)
16 Not yet recruiting To Assess Efficacy of Olaparib Maintenance Monotherapy at Preventing or Delaying the Return of the Cancer
Condition: BRCAm Ovarian Cancer
Intervention: Drug: Olaparib
17 Recruiting Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel
Conditions: Ovarian Cancer;   Endometrial Cancer;   Cervical Cancer;   Breast Cancer Triple Negative
Intervention: Drug: ARQ 092 + carboplatin + paclitaxel
18 Not yet recruiting A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Condition: Ovarian Cancer
Interventions: Drug: Cisplatin and doxorubicin;   Procedure: Cisplatin and doxorubicin
19 Not yet recruiting Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasm
Interventions: Other: Placebo;   Drug: Veliparib;   Drug: Carboplatin;   Drug: Paclitaxel
20 Recruiting Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
Conditions: Malignant Ovarian Clear Cell Tumor;   Malignant Ovarian Serous Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer
Interventions: Biological: Aldesleukin;   Biological: HER2Bi-Armed Activated T Cells;   Other: Laboratory Biomarker Analysis;   Biological: Sargramostim

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years